How do I prepare for a monitoring visit?

How do I prepare for a monitoring visit?

Sites: How To Prepare For A Clinical Monitoring Visit

  1. Review Data Entry. First and foremost, ensure all data has been entered and submitted to the CRO/Sponsor.
  2. Review Action Items from the Last Clinical Monitoring Visit.
  3. Review the Regulatory Binder.
  4. Invite the PI to the Monitoring Visit.
  5. Check Meeting Times and Locations.

What needs to be in a regulatory binder?

Organizing Your Regulatory Binder

  • Site Visit (Monitoring) Log.
  • Delegation of Authority (Responsibilities) Log.
  • Site Personnel Signature Log.
  • Study Personnel Education.
  • 4.1 Training Log.
  • CVs/Financial Disclosures/Investigator Statements.
  • Public Registration of Research Studies (PRS) (If applicable)
  • Screening/Enrollment Log.

What is the purpose of a regulatory binder?

A regulatory binder or regulatory file contains all study-specific information and regulatory documentation in a centralized location. It organizes essential documents, provides easy access to essential documents for review/audit purposes, and allows study team members to reference information.

What is the purpose of an investigator’s brochure?

The Investigator’s Brochure (IB) is a comprehensive compilation of clinical and nonclinical data on the investigational product (drug, supplement, device or other product) maintained by a drug developer or investigator that contains the body of information about the investigational product obtained before and during a …

At which study visits can the site expect?

At which study visits can the site expect the sponsor to review subjects’ signed informed consent forms? Periodic and termination site visits. The subject informed consent forms are reviewed at the periodic site visits and the termination site visit.

What is a monitoring visit report?

The monitoring visit report is the full confirmation of monitoring processes at investigational sites.

Who is responsible for regulatory binder?

Study coordinators or individuals responsible for establishing the Essential Document Binder ( synonyms: Investigator Binder , Regulatory Binder, Investigational Site File (ISF), or Study Binder).

What is a FDA Form 1571?

The FDA Form 1571 or ‘1571’ is the IND application cover page and it must accompany the initial IND submission and any amendments, IND safety reports, annual reports or general correspondence the sponsor submits to the FDA about the IND. The 1571 is a contractual agreement between the sponsor and the FDA.

What is in a regulatory packet?

The SRP typically consists of the following documents: Form FDA 1572, principal investigator curriculum vitae, signed protocol signature page, site-specific ICF/IAF (back-translated into English if the local language is other than English), privacy requirements (e.g., HIPAA, PIPEDA), IRB/IEC membership, and country- …

What are the responsibilities of investigators?

Investigators are responsible for supervising the proper handling, administration, storage, and destruction of investigational agents (ie, drug accountability). Although these tasks can be delegated to an appropriately qualified individual, the investigator maintains ultimate responsibility.

What is e6r2?

E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1) March 2018. The objective of this ICH GCP guidance is to provide a unified standard for the European Union, Japan, and the United States to facilitate the mutual acceptance of clinical data by the regulatory authorities in these jurisdictions.

What is a site qualification visit?

Site Qualification Visit (SQV): A meeting with a representative from a sponsor representative to ensure the institution is fully capable and equipped to run a specific clinical trial. This visit may also be referred to as Site Selection Visit (SSV) or Pre-Study Qualification Visit (PSQV).

How to protect information subject to data privacy regulation?

Data privacy regulations for information protection recommend: Protection against loss or unauthorized access, usage and/or transmission. Risk-based application of protective mechanisms. Use of encryption where appropriate.

Why is the FDA required to monitor research?

They ensure that the reporting of adverse events is complete. This very useful auditing function serves to promote Good Clinical Practices and to enhance the compulsive collection of data. It is required by the FDA, which does not like to review incomplete studies. These monitors do not relate to the subjects.

Why is the FDA required to review adverse event reports?

They meet periodically with research coordinators and review their study records. They ensure that the reporting of adverse events is complete. This very useful auditing function serves to promote Good Clinical Practices and to enhance the compulsive collection of data. It is required by the FDA, which does not like to review incomplete studies.

How does monitoring research relate to research integrity?

Monitoring Research(page 1 of 2) Research by its very nature is a trip into the unknown for the subjects as well as for the entire investigator team. While the IRB has some monitoring responsibilities, it is not constituted so as to visit sites, examine data, interact with subjects, or make decisions as to the nature of an adverse event.